Week of November 14, 2023 | Vol. 12, Issue 45

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

Let's Meet!

Please reach out to Xan Smith to schedule a meeting with Bourne Partners in the following locations:

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Research

Insight Into Healthcare Related Industries

Bourne Brief

Trial & Error: Navigating Tailwinds & Headwinds in Clinical Research Service

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Matador

Pharma | Sell-Side

Acquisition opportunity of two sterile injectable ANDAs

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO

Project Pearl

Pharma | Capital Raise

Investment opportunity in late clinical-stage biopharmaceutical company

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable pharmaceutical manufacturer 

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Landmark Bio Signs Multi-Year Agreement to Manufacture Galapagos' Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-Care

PR Newswire - Nov 6, 2023

Cellares and Cabaletta Bio Partner to Evaluate Automated Manufacturing for CABA-201, Cabaletta’s CD19-CAR T Cell Therapy on Cellares’ Cell Shuttle Platform

Business Wire - Nov 6, 2023

BioCina Expands Partnership with GPN Vaccines

BioCina - Nov 6, 2023

Everest Clinical acquires August Research for undisclosed price

Fierce Biotech - Nov 8, 2023

Alloy Therapeutics, Wheeler Bio Partner on CMC Development

Contract Pharma - Nov 8, 2023

Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs

Avid Bioservices - Nov 8, 2023

The CDMO/CMO Report: The Market For High-Potency Manufacturing

DCAT Value Chain Insights - Nov 9, 2023

Andelyn Biosciences and The Ohio State University Collaborate for Pre-clinical and GMP Manufacturing of Novel Gene Therapies

PR Newswire - Nov 9, 2023

GenScript ProBio Signs Viral Vector Manufacturing MOU With Curocell for Next-Generation CAR-T Therapy

Business Wire - Nov 10, 2023

TANNER NEWS

Sponsoring the Max Global Experience: Cambodia

We’re proud to have sponsored The Max Foundation's "Max Global Experience: Cambodia." Our EVP of Managed Access Programs, Robert Keel, joined this year’s journey to the heart of Cambodia, where he had the privilege of meeting with local partners and patients. 

💡 Check out the full article to learn more about the experience and the patients.